Data supporting extra COVID19 risk for Blood C... - CLL Support
Data supporting extra COVID19 risk for Blood Cancer patients
You need to be a member of this community to see this post.
Read more about...
41 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
The lowdown on Covid vaccine efficacy and blood cancer
Around 152,000 people in the UK have died with Covid19 on their death certificate.
Around 230,000...
Factors Identified for Risk of Second Cancer in CLL Following BTK Inhibition
There was hope that non-chemo CLL treatments would avoid the increased risk of subsequent secondary...
Latest COVID-19 guide for immunocompromised blood cancer patients from the International COVID-19 Blood Cancer Coalition (ICBCC)
The latest Patient Impact Statement has been released by the International COVID-19 Blood Cancer...
Does having CLL really make you 3 times more likely to get (another) cancer, and does CLL treatment add to the risk? - Part 1
1. The risk of developing a Secondary Primary Malignancy
"The higher risk of SPM...
Support for CLL Patients
This HU site, where we share information, experiences and friendship is a massive support for many...
Related Posts
Shielding advice by UK GOVERNMENT - Cancer experts offer guidance on COVID-19 vaccination for patients with blood cancer, including Chronic Lymphocytic Leukaemia (CLL)
- Blood donors relax. There is negligible risk of CLL transmission via blood donation!
- Relative risk for secondary bone marrow cancer within 5 years after initial CLL chemoimmunotherapy treatment (typically BR or FCR)
New study indicates the value of booster vaccinations and monoclonal antibody (Evusheld) protection to blood cancer patients
